Remodeling of the hypertrophied human myocardium by cardiac bHLH transcription factors

Journal of Cellular Biochemistry

Volumn 74, Issue 4, 1999, Pages 551-561

  Ritter, Oliver ^a,b   Haase, Hannelore ^a   Schulte, Hagen Dieter ^c   Lange, Peter E ^d   Morano, Ingo ^a,e  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b FRANZ VOLHARD CLINIC   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

ALC 1; Antisense; dHAND; eHAND; Hypertrophic cardiomyopathy; Tetralogy of Fallot

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; DNA SEQUENCE; GENE TARGETING; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; MESODERM; NEURAL CREST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

EID: 0033567836     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990915)74:4<551::AID-JCB5>3.0.CO;2-9     Document Type: Article

References (25)

1. Boheler KR, Chassagne C, Martin X, Wisnewsky C, Schwartz K. 1992. Cardiac expressions of α-and β-myosin heavy chains and sarcomeric α-actins are regulated through transcriptional mechanisms. J Biol Chem 267: 12979-12985.
2. Catala F, Wanner R, Barton P, Cohen A, Wright W, Buckingham M. 1995. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promotor of the mouse myosin light chain 1A gene. Mol Cell Biol 15:4585-4596.
3. Chomczynski P, Sacchi N. 1987. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
4. Cserjesi P, Brown D, Lyons GE, Olson EN. 1995. Expression of the novel basic Helix-Loop-Helix gene eHAND in neural crest derivatives and extraembryonic membranes during mouse development. Dev Biol 170:664-678.
5. Fewell JG, Hewett TE, Sambe A, Klevitsky R, Hayes E, Warshaw D, Maughan D, Robbins J. 1998. Functional significance of cardiac myosin light chain isoform switching in transgenic mice. J Clin Invest 101:2630-2639.
6. Firulli AB, McFadden DG, Lin Q, Srivastava D, Olson EN. 1998. Heart and extra-embryonic mesodermal defects in mouse embryos lacking the bHLH transcription factor HAND1. Nature Genet 18:266-275.
7. Herzig TC, Jobe SM, Akoi H., Molkentin JD, Cowley AW, Izumo S, Markham BE. 1997. Angiotensin II type 1a receptor gene expression in the heart: AP-1 and GATA 4 mediate the response to pressure overload. Proc Natl Acad Sci USA 94:7543-7548.
8. Hollenberg SM, Sternglatz R, Cheng PF, Weintraub H. 1995. Identification of a new familiy of tissue specific basic helix-loop-helix proteins with a two hybrid system. Mol Cell Biol 15:3813-3822.
9. Kirklin JW, Blackstone EH, Pacifico AD. 1992. Morphologic and surgical determinants of outcome events after repair of tetralogy of Fallot and pulmonary atenosis. J Thorac Cardiovasc Surg 103:706-723.
10. Luther HP, Morwinski R, Wallukat G, Haase H, Morano I. 1997. Expression of sense and naturally occurring antisense mRNA of myosin heavy chain in rat heart tissue and cultivated cardiomyocytes. J Mol Cell Cardiol 29: 27-31.
11. Luther H., Haase H, Hohaus A, Beckmann G, Reich J, Morano I. 1998. Characterization of naturally occurring antisense mRNA in the rat heart. J Cell Biochem 70:110-120.
12. Marino R, Haldar S, Williamson F, Beaverson K, Walter R, Marino D, Beatty C, Lipson K. 1991. Proliferating cell nuclear antigen in developing and adult cardiac muscle cells. Circ Res 69:1353-1360.
13. McCarthy TL, Siegel E, Mroczowski B, Heywood SM. 1983. Characterization of translational control - "ribonucleic acid isolated from embryonic chick muscle. Biochem 22: 935-941.
14. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robins J, Grant SR, Olson EN. 1998. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228.
15. Morano M, Zacharzowski U, Maier M, Lange PE, Alexi-Meskishvili V, Haase H, and Morano I. 1996. Regulation of human contractility by essential myosin light chain isoforms. J Clin Invest 98:467-473.
16. Morano I, Hädicke K, Haase H, Böhra M, Erdmann E, Schaub MC. 1997. Changes in essential myosin light chain isoform expression provide a molecular basis for isometric force regulation in the failing human heart. J Mol Cell Cardiol 29:1177-1187.
17. Morrow AG, Reitz BA, Epstein SE. 1975. Operative treatment in hypertrophic subaortic stenosis: techniques and the results of pre-and postoperative assessments in 83 patients. Circulation 52:88-102.
18. Olson EN, Klein WH. 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 8:1-8.
19. Russell MW, Baker P, Izumo S. 1997. Cloning, chromosomal mapping and expression of the human eHAND gene. Mammal Gen 8:863-865.
20. Schaub MC, Hefti MA, Zuellig RA, Morano I. 1998. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovasc Res 37:381-404.
21. Schulte HD, Bircks WH, Loesse B, Godehardt EAJ, Schwartzkopff B. 1993. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. J Thorac Cardiovasc Surg 106:709-717.
22. Srivastava D, Cserjesi P, Olson EN. 1995. A subclass of bHLH proteins required for cardiac morphogenesis. Science 270:1995-1999.
23. Srivastava D, Thomas T, Lin Q, Kirby ML, Brown D, Olson EN. 1997. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nature Genet 16:154-160.
24. Thomas T, Yamagishi H, Overbeek PA, Olson EN, Srivastava D. 1998. The bHLH Factors, dHAND and eHAND, specify pulmonary and systemic cardiac ventricles independent of left-right sideness. Dev Biol 196:228-236.
25. Zimmermann K, Kautz S, Hajdu G, Winter C, Whalen RG, Starzinski-Powitz A. 1990. Heterogenic mRNA's with an identical protein coding region of the human embryonic myosin alkali light chain in skeletal muscle cells. J Mol Biol 211:505-513.